MedTrace Logo

French National Registry of Rare Peritoneal Surface Malignancies

NCT02834169 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2171

Last updated 2017-08-22

No results posted yet for this study

Summary

Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.

In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.

All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.

Conditions

  • Rare Peritoneal Surface Malignancies
  • Pseudomyxoma Peritonei
  • Peritoneal Mesothelioma
  • Desmoplastic Small Round Cell Tumor
  • Psammocarcinoma
  • Primary Peritoneal Serous Carcinoma
  • Diffuse Peritoneal Leiomyomatosis
  • Appendiceal Mucinous Neoplasms

Interventions

OTHER

Non interventional

Data collection

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • François-Noël GILLY, Prof · Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet, PIERRE-BENITE, FRANCE, 69495

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02834169 on ClinicalTrials.gov